Joseph J. Larosa, EVP General Counsel and Secret at REGENERON PHARMACEUTICALS, INC. (REGN), sold 18,280 shares at $484.58 ($8.9M) on 2020-04-02, disclosed to the SEC on 2020-04-03.
Open-market sale of $8.9M REGN by EVP General Counsel and Secret. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $488.22 | 2,689 | $1.3M | 14.7% |
| 2 | $488.22 | 2,757 | $1.3M | 15.0% |
| 3 | $484.58 | 192 | $93K | 1.0% |
| 4 | $484.58 | 192 | $93K | 1.0% |
| 5 | $485.65 | 441 | $214K | 2.4% |
| 6 | $485.65 | 441 |
| $214K |
| 2.4% |
| 7 | $486.61 | 485 | $236K | 2.6% |
| 8 | $486.61 | 485 | $236K | 2.6% |
| 9 | $487.71 | 470 | $229K | 2.6% |
| 10 | $487.71 | 470 | $229K | 2.6% |
| 11 | $488.26 | 1,626 | $794K | 8.9% |
| 12 | $488.26 | 1,626 | $794K | 8.9% |
| 13 | $489.72 | 734 | $359K | 4.0% |
| 14 | $489.72 | 734 | $359K | 4.0% |
| 15 | $490.32 | 484 | $237K | 2.7% |
| 16 | $490.32 | 484 | $237K | 2.7% |
| 17 | $491.42 | 450 | $221K | 2.5% |
| 18 | $492.62 | 521 | $257K | 2.9% |
| 19 | $492.62 | 521 | $257K | 2.9% |
| 20 | $493.35 | 652 | $322K | 3.6% |
| 21 | $493.35 | 652 | $322K | 3.6% |
| 22 | $494.36 | 111 | $55K | 0.6% |
| 23 | $494.36 | 111 | $55K | 0.6% |
| 24 | $495.19 | 321 | $159K | 1.8% |
| 25 | $495.19 | 321 | $159K | 1.8% |
| 26 | $496.50 | 210 | $104K | 1.2% |
| 27 | $497.32 | 100 | $50K | 0.6% |
| Total | $489.31 avg | 18,280 | $8.9M | 100% |
| Filing → |
| REGN | SELL | 2024-02-28 | $990K | — | Filing → |
| REGN | SELL | 2024-02-26 | $968K | — | Filing → |
| REGN | SELL | 2024-02-09 | $950K | — | Filing → |